Lipigon Pharmaceuticals AB's total assets for Q1 2025 were kr36.42M, an increase of 145.68% from the previous quarter. DE:9RP total liabilities were kr7.17M for the fiscal quarter, a 1.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.